Prevalence of DNA Mismatch Repair Deficiency in Endometrial Cancer Using Immunohistochemistry

被引:0
|
作者
Mehdizadeh, Behnoush [1 ]
Gharib, Masoumeh [2 ]
Jafarian, Amir Hossein [3 ]
Afzalaghaee, Monavvar [4 ]
Shandiz, Fateme Homaee [5 ]
Irajpour, Amirhosein [6 ]
机构
[1] Birjand Univ Med Sci, Dept Surg & Clin Pathol, Fac Med, Birjand, Iran
[2] Mashhad Univ Med Sci, Dept Pathol, Fac Med, Mashhad, Razavi Khorasan, Iran
[3] Mashhad Univ Med Sci, Canc Mol Pathol Res Ctr, Mashhad, Razavi Khorasan, Iran
[4] Mashhad Univ Med Sci, Dept Community Med, Mashhad, Razavi Khorasan, Iran
[5] Mashhad Univ Med Sci, Dept RadioOncol, Canc Res Ctr, Fac Med, Mashhad, Razavi Khorasan, Iran
[6] Shahid Beheshti Univ Med Sci, Dept Surg, Tehran, Iran
关键词
Lynch Syndrome; Endometrial Cancer; Immunohistochemistry; NONPOLYPOSIS COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; LYNCH-SYNDROME; RISK; ASSOCIATION; EXPRESSION; MUTATIONS;
D O I
10.5812/ijcm-119065
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Endometrial cancer (EC) is known as the most common malignancy of the female reproductive system, suggested to be associated with hereditary nonpolyposis colorectal cancer (HNPCC) or Lynch syndrome (LS). Objectives: Therefore, the aim of the present study was to screen for LS in patients with EC using immunohistochemistry (IHC). Methods: In this retrospective cross-sectional study, the patients with EC, referred to Qaem Hospital, Mashhad, Iran, from 2015 2019, were enrolled. Paraffin-embedded tissue blocks were then examined via IHC for the expression of four mismatch repair (MMR) proteins, includingMLH1, MSH2, MSH6, andPMS2. Thedemographicandtumor-related datawerealso extractedfrommedical records and pathology reports. The data were consequently analyzed at the significance level of P < 0.05. Results: A total number of 100 patients with EC were evaluated using IHC, and 12 (12%) cases were found suspected. As well, no significant relationship was observed between LS and age, tumor site, tumor histology, tumor size, tumor grade, tumor-infiltrating lymphocytes (TILs), and a family/personal history of malignancies. Conclusions: The prevalence of LS based on the IHC expression of the MMR proteins (MLH1, MSH2, MSH6, and PMS2) was 12% in the patients with EC. There was also no significant relationship between the cases suspected and the demographic and tumor-related data.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Mismatch Repair Deficiency in Endometrial Carcinosarcomas
    Dillon, Jessica
    Tafe, Laura
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 1047 - 1047
  • [22] Clinical characterization of DNA mismatch repair deficiency (MMR-D) in endometrial cancer (EC).
    Cadoo, Karen Anne
    Tran, Christina
    DeLair, Deborah
    Arnold, Angela G.
    Ashraf, Asad
    Jewell, Elizabeth Lin
    Kauff, Noah D.
    Long, Kara
    Mueller, Jennifer Jean
    Robson, Mark E.
    Schiavone, Maria
    Trottier, Magan
    Soslow, Robert A.
    Offit, Kenneth
    Aghajanian, Carol
    Stadler, Zsofia Kinga
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [23] DNA mismatch repair deficiency in early-onset endometrial carcinomas
    Walsh, Michael
    Young, Joanne
    Cummings, Margaret
    Buchanan, Daniel
    Barker, Melissa
    Gattas, Michael
    Leggett, Barbara
    Jeremy, Jass
    Spurdle, Amanda
    Obermair, Andreas
    MODERN PATHOLOGY, 2006, 19 : 104 - 105
  • [24] Evaluation of DNA Mismatch Repair Protein Deficiency in Primary Endometrial Carcinoma
    Kumar, Pankaj
    Gupta, Parikshaa
    Gupta, Nalini
    Rajwanshi, Arvind
    Rai, Bhavana
    Shalini, Gainder
    JOURNAL OF GYNECOLOGIC SURGERY, 2019, 35 (03) : 177 - 183
  • [25] Mismatch repair immunohistochemistry in endometrial cancer: Intact vs. deficient is insufficient
    Riedinger, Courtney
    Esnakula, Ashwini
    Suarez, Adrian
    Chen, Wei
    Cohn, David
    Goodfellow, Paul
    Cosgrove, Casey
    GYNECOLOGIC ONCOLOGY, 2022, 166 : S129 - S129
  • [26] CLINICAL AND PATHOLOGICAL FEATURES OF ENDOMETRIAL CANCER PATIENTS WITH DNA MISMATCH REPAIR DEFICIENCY TREATED AT A BRAZILIAN CANCER HOSPITAL
    Mayerhoff, E.
    Anton, C.
    Wagner, M.
    Carvalho, J.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A83 - A84
  • [27] Case report of endometrial cancer with a microcytic, elongated, and fragmented pattern of invasion and DNA mismatch repair deficiency
    Sookram, Janhvi
    Barroeta, Julieta E.
    Aikins, James K.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2018, 141 (02) : 252 - 254
  • [28] Mismatch repair deficiency and survival in stage I endometrial cancer.
    Broaddus, Russell R.
    CLINICAL CANCER RESEARCH, 2021, 27 (03)
  • [29] Assessment of Immune Status in Patients with Mismatch Repair Deficiency Endometrial Cancer
    Ma, Jincheng
    Lin, Jiansong
    Lin, Xite
    Ren, Yuan
    Liu, Dabin
    Tang, Shuting
    Huang, Leyi
    Xu, Shuxia
    Mao, Xiaodan
    Sun, Pengming
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 2039 - 2050
  • [30] Practical guidance for mismatch repair-deficiency testing in endometrial cancer
    Stelloo, E.
    Jansen, A. M. L.
    Osse, E. M.
    Nout, R. A.
    Creutzberg, C. L.
    Ruano, D.
    Church, D. N.
    Morreau, H.
    Smit, V. T. H. B. M.
    van Wezel, T.
    Bosse, T.
    ANNALS OF ONCOLOGY, 2017, 28 (01) : 96 - 102